Supplementary table 2.docx: A Phase I trial of talazoparib in patients witha dvanced hematologic malignancies
收藏数据链接:
官方服务:
资源简介:
<b>Supplementary Table 2. </b>Exposure to talazoparib (safety population). <b></b>
创建时间:
2021-10-23

<b>Supplementary Table 2. </b>Exposure to talazoparib (safety population). <b></b>